Update: Amgen Kidney Disease Drug Under Scrutiny in Japan
Amgen Inc AMGN
$323.79
▼ -0.77%
($-2.52)
Index member:
S&P 500
NASDAQ-100
Dow Jones
Open
$325.27
Prev Close
$326.31
Day Range
$321.21 – $325.77
52W Range
$264.15 – $391.29
Market Cap
$177.88B
P/E (TTM)
22.45
Beta
0.43
Div Yield
3.09%
EPS (TTM)
$14.38
📋 Company Profile
| Industry | Biotechnology |
| Sector | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1983-06-17 |
| Shares Out. | 539,690,000 |
| Website | amgen.com/ ↗ |
| Phone | 18009279800 |
Amgen Inc is a publicly traded company under the ticker symbol AMGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
44 analysts (2026-05-01)
📰 Latest News for AMGN
Amgen Japanese Partner Urges Caution On Tavneos Use
Middle East and Africa Wearable Injectors Market Trends and Forecast Report 2026-2035 Featuring Amgen, BD, Biocon, Gerresheimer, Insulet, J&J, Medtronic, Roche, West Pharmaceutical, Ypsomed
3 Top Dividend Stocks to Maximize Your Retirement Income
Høeg fired in latest FDA shakeup; 20 people die after taking Amgen drug
Up 231%, Is RTX Proving Why It Was a Mistake for Honeywell to Replace RTX in the Dow Jones Industrial Average?
Amgen : Statement on TAVNEOS® (avacopan)
Amgen : 2026 Annual Meeting of Stockholders Presentation Non GAAP Reconciliations